About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,044 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,044 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5261-5280 of 8,044 trials

TerminatedTrial Of CP-751, 871 And Erlotinib In Refractory Lung CancerThe objective of this study is to test a clinical benefit of the addition of CP 751,871 to erlotinib therapy in patients with advanced NSCLC of non adenocarcinoma histology.NCT00673049·Fort Smith, Arkansas and 174 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingSurgical Strategy of NSCLC Patients After Neo-adjuvant or Induction TreatmentLung cancer is one of the most common malignant tumors worldwide and has the highest mortality rate among malignant tumors.NCT06534489·Shanghai

Not yet recruitingMinimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLCThis investigator-initiated study aims to evaluate the effectiveness of minimal residual disease (MRD) as a biomarker for guiding adjuvant therapy decisions in patients with Stage…NCT06709274·Dongguan, Guangdong and 14 others

Not yet recruitingNeoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLCSurgical intervention remains the primary treatment option for early-stage lung cancer.NCT06837948·Shanghai

RecruitingStudy on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple MetastasesThis study aims to conduct a prospective, multicenter, umbrella clinical study to compare the abscopal effects of different radiotherapy fractionation patterns combined with…NCT06953843·Chongqing, Chongqing Municipality

CompletedPrognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung CancerGrowing evidence has confirmed that the prognosis of lung cancer is not only related to the stage of disease, but also to the physiological and psychological situation of the…NCT05212285·Shanghai, Shanghai Municipality

UnknownVerification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal MetastasisThe purpose of this study is to learn whether our own made predictive algorithm can be used as a clinical practical decision support for patients with NSCLC spinal metastasis.NCT03363685·Shanghai, Shanghai Municipality

Active not recruitingFirst-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKIThis is an open label, multi-center, Phase 1/2 study evaluating the safety, tolerability, PK, PD, and preliminary efficacy (antitumor activity) of BBT-207.NCT05920135·Seongnam-si, Gyeonggi-do and 2 others

RecruitingA Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)This trial will evaluate the efficacy and safety of various therapies in participants with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated NSCLC tumors that…NCT04302025·Duarte, California and 37 others

UnknownThymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild TypeThymosin alpha 1 plus maintenance therapy with the Standard of Care (SoC) chemotherapy plus cisplatin (or carboplatin) in patients with metastatic Non-Small Cell Lung Cancer…NCT02906150·Frosinone and 7 others

UnknownDose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable DiseaseThe primary purposes of this study are to assess the safety and efficacy of using high doses of the drug Icotinib (Conmana) as a way to treat patients with non-small cell lung…NCT01690390·Fuzhou, Fujian and 16 others

TerminatedStudy of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)The combination of chemotherapy with radiotherapy remains the standard of therapy for patients with stage III NSCLC.NCT00431613·Heraklion, Crete and 9 others

WithdrawnPembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung CancerThe purpose of this study is to see whether patients who have early stage NSCLC bigger than a certain size might benefit from receiving additional medicinal drug to treat their…NCT03574220

Active not recruitingA Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLCThis study will evaluate the efficacy, safety, pharmacokinetics and immunogenicity of RC148 injection as a single agent or in combination for the treatment of locally advanced or…NCT06883630·Beijing, Beijing Municipality and 23 others

CompletedTrial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung CancerThe main purpose of the study is to determine the activity of the weekly combination of docetaxel (Taxotere) and irinotecan in terms of response rate in subjects with advanced…NCT00819728·Bridgewater, New Jersey

RecruitingAdjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung CancerThe use of neoadjuvant immuno-chemotherapy could improve survival outcomes of patients eligible for sequential radio-chemotherapy comparing to the benefit already obtained with…NCT06656598·Angers and 24 others

CompletedDetection of Early Metastases in Patients With Stage I Non-small Cell Lung CancerRATIONALE: Detecting very early metastases in bone marrow and/or lymph nodes may help doctors plan better treatment for non-small cell lung cancer.NCT00003006·Iowa City, Iowa and 9 others

TerminatedNimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung CancerNimotuzumab is a humanized monoclonal anti-body targeting the epidermal growth factor receptor (EGFR).NCT00983047·Beijing

RecruitingTo Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant ChemotherapyThis is a phase II, prospective, multi-centre study.NCT06192849·Chengdu, Sichuan

CompletedTrial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)This is a Phase 1b pre-operative lung cancer trial wherein patients with operable lung cancer will be treated with RAD001 to evaluate the target effects of this compounds on…NCT00401778·Atlanta, Georgia

PreviousPage 264 of 403Next